• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性乙型肝炎患者自然发生乙型肝炎e抗原血清学转换前两种临床事件中血清乙型肝炎病毒DNA的变化

Changes of serum hepatitis B virus DNA in two types of clinical events preceding spontaneous hepatitis B e antigen seroconversion in chronic type B hepatitis.

作者信息

Liaw Y F, Pao C C, Chu C M, Sheen I S, Huang M J

出版信息

Hepatology. 1987 Jan-Feb;7(1):1-3. doi: 10.1002/hep.1840070102.

DOI:10.1002/hep.1840070102
PMID:2433201
Abstract

Two types of clinical events, acute exacerbation and uneventful course, precede spontaneous HBeAg seroconversion to its antibody (anti-HBe) in chronic type B hepatitis. To examine the possible mechanism responsible for these two types of clinical events, serial serum specimens from 75 patients who underwent spontaneous HBeAg seroconversion were assayed for hepatitis B virus DNA by slot blot hybridization with 32P-labeled cloned hepatitis B virus DNA as probe. Of these 75 patients, 47 (62.7%) had episodes of acute exacerbation (ALT greater than 300 IU per liter) within 3 months prior to HBeAg seroconversion. All of these 47 patients had high hepatitis B virus DNA levels (greater than 1,000 pg per ml) at the onset of acute exacerbation. Their serum hepatitis B virus DNA disappears shortly before or simultaneously with the HBeAg clearance in 27 patients (57.4%) and persisted but with decreasing levels for 2 to 40 months in 20 patients. Most of these patients had high alpha-fetoprotein levels or evidence of bridging hepatic necrosis. In contrast, the serum hepatitis B virus DNA was undetectable for a minimum of 3 (3-17) months in the 28 patients who had an uneventful course before HBeAg seroconversion. Twenty of these 28 patients had well-documented episodes of acute exacerbation with high hepatitis B virus DNA levels, but with normal alpha-fetoprotein and little evidence of extensive necrosis as far back as 6 to 27 months before HBeAg seroconversion.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

在慢性乙型肝炎中,两种临床事件,即急性加重和病情平稳,先于HBeAg自发血清学转换为其抗体(抗-HBe)。为了研究导致这两种临床事件的可能机制,对75例经历HBeAg自发血清学转换的患者的系列血清标本,用32P标记的克隆乙肝病毒DNA作为探针,通过斑点杂交法检测乙肝病毒DNA。在这75例患者中,47例(62.7%)在HBeAg血清学转换前3个月内有急性加重发作(谷丙转氨酶大于300 IU/升)。这47例患者在急性加重发作时乙肝病毒DNA水平均较高(大于1000 pg/ml)。其中27例患者(57.4%)的血清乙肝病毒DNA在HBeAg清除前或同时消失,20例患者的血清乙肝病毒DNA持续存在但水平下降,持续2至40个月。这些患者大多甲胎蛋白水平较高或有桥接性肝坏死证据。相比之下,在HBeAg血清学转换前病情平稳的28例患者中,血清乙肝病毒DNA至少3(3 - 17)个月检测不到。这28例患者中有20例有记录明确的急性加重发作,乙肝病毒DNA水平较高,但甲胎蛋白正常,早在HBeAg血清学转换前6至27个月几乎没有广泛坏死的证据。(摘要截选至250字)

相似文献

1
Changes of serum hepatitis B virus DNA in two types of clinical events preceding spontaneous hepatitis B e antigen seroconversion in chronic type B hepatitis.慢性乙型肝炎患者自然发生乙型肝炎e抗原血清学转换前两种临床事件中血清乙型肝炎病毒DNA的变化
Hepatology. 1987 Jan-Feb;7(1):1-3. doi: 10.1002/hep.1840070102.
2
Acute exacerbation in chronic type B hepatitis: comparison between HBeAg and antibody-positive patients.
Hepatology. 1987 Jan-Feb;7(1):20-3. doi: 10.1002/hep.1840070106.
3
Demonstration of hepatitis B virus DNA by polymerase chain reaction in the serum and the liver after spontaneous or therapeutically induced HBeAg to anti-HBe or HBsAg to anti-HBs seroconversion in patients with chronic hepatitis B.慢性乙型肝炎患者在自发或经治疗诱导HBeAg血清学转换为抗-HBe或HBsAg血清学转换为抗-HBs后,通过聚合酶链反应检测血清和肝脏中的乙型肝炎病毒DNA
Hepatology. 1992 Jan;15(1):32-6. doi: 10.1002/hep.1840150107.
4
Changes of serum hepatitis B virus DNA and aminotransferase levels during the course of chronic hepatitis B virus infection in children.儿童慢性乙型肝炎病毒感染过程中血清乙肝病毒DNA及转氨酶水平的变化
Hepatology. 1990 Oct;12(4 Pt 1):657-60. doi: 10.1002/hep.1840120406.
5
Recombinant interferon-alpha 2a hastens the rate of HBeAg clearance in children with chronic hepatitis B.重组干扰素α-2a可加快慢性乙型肝炎患儿HBeAg的清除率。
Hepatology. 1994 Aug;20(2):287-90.
6
Precore wild-type DNA and immune complexes persist in chronic hepatitis B after seroconversion: no association between genome conversion and seroconversion.血清转换后,前核心野生型DNA和免疫复合物在慢性乙型肝炎中持续存在:基因组转换与血清转换之间无关联。
Hepatology. 1998 Jan;27(1):245-53. doi: 10.1002/hep.510270137.
7
A three-month course of lamivudine therapy in HBeAg-positive hepatitis B patients with normal aminotransferase levels.对谷丙转氨酶水平正常的HBeAg阳性乙肝患者进行为期三个月的拉米夫定治疗。
Turk J Gastroenterol. 2004 Mar;15(1):14-20.
8
Models for predicting hepatitis B e antigen seroconversion in response to interferon-α in chronic hepatitis B patients.预测慢性乙型肝炎患者对α干扰素治疗产生乙肝e抗原血清学转换的模型
World J Gastroenterol. 2015 May 14;21(18):5668-76. doi: 10.3748/wjg.v21.i18.5668.
9
Is it necessary to delay antiviral therapy for 3-6 months to anticipate HBeAg seroconversion in patients with HBeAg-positive chronic hepatitis B in endemic areas of HBV genotype C?在HBV C基因型流行地区,HBeAg阳性慢性乙型肝炎患者是否有必要延迟3至6个月进行抗病毒治疗以期待HBeAg血清学转换?
Clin Mol Hepatol. 2014 Dec;20(4):355-60. doi: 10.3350/cmh.2014.20.4.355. Epub 2014 Dec 24.
10
Predictive factors for early HBeAg seroconversion in acute exacerbation of patients with HBeAg-positive chronic hepatitis B.HBeAg阳性慢性乙型肝炎患者急性加重期早期HBeAg血清学转换的预测因素
Gastroenterology. 2009 Feb;136(2):505-12. doi: 10.1053/j.gastro.2008.10.089. Epub 2008 Nov 27.

引用本文的文献

1
Immunogenicity and Antiviral Response of Therapeutic Hepatitis B Vaccination in a Mouse Model of HBeAg-Negative, Persistent HBV Infection.治疗性乙肝疫苗在HBeAg阴性、持续性HBV感染小鼠模型中的免疫原性和抗病毒反应
Vaccines (Basel). 2021 Jul 31;9(8):841. doi: 10.3390/vaccines9080841.
2
Transaminase Elevations during Treatment of Chronic Hepatitis B Infection: Safety Considerations and Role in Achieving Functional Cure.治疗慢性乙型肝炎感染期间的转氨酶升高:安全性考虑因素及实现功能性治愈的作用。
Viruses. 2021 Apr 23;13(5):745. doi: 10.3390/v13050745.
3
INASL Guidelines on Management of Hepatitis B Virus Infection in Patients receiving Chemotherapy, Biologicals, Immunosupressants, or Corticosteroids.
意大利肝脏研究学会(INASL)关于接受化疗、生物制剂、免疫抑制剂或皮质类固醇治疗的乙型肝炎病毒感染患者管理的指南。
J Clin Exp Hepatol. 2018 Dec;8(4):403-431. doi: 10.1016/j.jceh.2018.06.010. Epub 2018 Jun 26.
4
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance.慢性乙型肝炎的预防、诊断和治疗最新进展:美国肝病研究学会2018年乙型肝炎指南
Hepatology. 2018 Apr;67(4):1560-1599. doi: 10.1002/hep.29800.
5
Chronic Hepatitis B with Spontaneous Severe Acute Exacerbation.慢性乙型肝炎伴自发性严重急性加重
Int J Mol Sci. 2015 Nov 26;16(12):28126-45. doi: 10.3390/ijms161226087.
6
Prevention and Management of Chronic Hepatitis B.慢性乙型肝炎的预防与管理
Int J Prev Med. 2014 Dec;5(Suppl 3):S200-7.
7
Acute exacerbation of chronic hepatitis B: the dilemma of differentiation from acute viral hepatitis B.慢性乙型肝炎急性加重:与急性乙型病毒性肝炎鉴别的困境
J Clin Exp Hepatol. 2013 Dec;3(4):301-12. doi: 10.1016/j.jceh.2013.08.014. Epub 2013 Oct 17.
8
T cell subsets in chronic hepatitis B and the effect of prednisolone withdrawal and interferon alpha-2b.慢性乙型肝炎中的T细胞亚群以及泼尼松龙撤药和α-2b干扰素的作用。
Korean J Intern Med. 1999 Jan;14(1):1-8. doi: 10.3904/kjim.1999.14.1.1.
9
Clinical significance of low or negative titer of antibody to hepatitis B core antigen during the course of chronic hepatitis B virus infection in adolescents.青少年慢性乙型肝炎病毒感染过程中乙肝核心抗原抗体低滴度或阴性的临床意义
Gastroenterol Jpn. 1993 Feb;28(1):25-33. doi: 10.1007/BF02775000.
10
Investigation of HBV infection status in anti-HBe Chinese patients with chronic hepatitis by in situ hybridization assay.应用原位杂交法检测抗-HBe阳性慢性乙型肝炎患者的HBV感染状态
J Tongji Med Univ. 1989;9(4):199-203. doi: 10.1007/BF02909083.